Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Integra LifeSciences Holdings (IART)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 72,108 | 0.01 | Buy | 0.01 | $9.42 | $679,257 | SEC |
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2024 Q1 | 9,419 | 0.01 | Add 8.87% | <0.01 | $35.45 | $333,904 | SEC |
| 2023 Q4 | 8,652 | 0.01 | Add 15.85% | <0.01 | $43.55 | $376,795 | SEC |
| 2023 Q3 | 7,468 | 0.01 | Reduce 26.02% | <0.01 | $38.19 | $285,203 | SEC |
| 2023 Q2 | 10,095 | 0.01 | Reduce 0.60% | <0.01 | $41.13 | $415,207 | SEC |
| 2023 Q1 | 10,156 | 0.01 | Add 65.76% | <0.01 | $57.41 | $583,056 | SEC |
| 2022 Q4 | 6,127 | 0.01 | Buy | 0.01 | $56.07 | $343,541 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q3 | 7,007 | <0.01 | Reduce 68.58% | <0.01 | $68.50 | $480,000 | SEC |
| 2021 Q2 | 22,299 | 0.01 | Add 126.34% | <0.01 | $68.25 | $1,522,000 | SEC |
| 2021 Q1 | 9,852 | 0.01 | Reduce 24.83% | <0.01 | $69.12 | $681,000 | SEC |
| 2020 Q4 | 13,106 | 0.01 | Reduce 37.27% | <0.01 | $64.93 | $851,000 | SEC |
| 2020 Q3 | 20,892 | 0.02 | Buy | 0.02 | $47.24 | $987,000 | SEC |